The HINARI (Health InterNetwork Access to Research Initiative) programme, established by WHO together with major publishers, enables developing countries to gain access to one of the world's largest collections of biomedical and health literature. More than 8500 journals and 7000 e-books (in 30 different languages) are available to health institutions in more than 100 countries, areas and territories benefiting many thousands of health workers and researchers, and in turn, contributing to improving world health.
Eligible countries in the Eastern Mediterranean Region
The two country lists (Group A and Group B) are based on three factors: gross national income per capita (World Bank figures), United Nations least-developed countries list and human development index (HDI).
Group A (free access)
Institutions in countries which meet at least one of the following criteria may be eligible for free access.
- Inclusion in the UN list of least-developed countries
- An HDI of less than 0.63
- Gross national income per capita at or below US$ 1600
Group B (low-cost access)
Institutions in countries that do not match at least one of the above criteria and with either a gross national income per capita less than US$ 5000 or HDI at or below 0.67 may be eligible to pay a fee of US$ 1000 per year (see list below of eligible countries in the Eastern Mediterranean Region).
Group A (free access)
- Afghanistan
- Djibouti
- Morocco
- Somalia
- South Sudan
- Sudan
- Syrian Arab Republic
- Occupied Palestinian territory
- Yemen
Group B (low-cost access)
- Iraq
- Jordan
- Tunisia
AGORA
Online Access to Research in the Environment (OARE), set up by the United Nations Environment Programme together with Yale University, and leading science and technology publishers, enables developing countries to gain access to one of the world’s largest collections of environmental science research. Over 4150 peer-reviewed titles published by over 350 prestigious publishing houses and scholarly societies covering all topics related to environmental research are available in more than 100 low-income countries.
